Sveriges mest populära poddar
The Long Run with Luke Timmerman
Vetenskap

Ep201: Jeremy Levin on Biotech in the Balance

1 tim 9 min•19 maj 2026
Jeremy Levin, executive chair of Ovid Therapeutics, discusses his new book "Biotech in the Balance: Saving a Strategic Industry in an Age of Distrust."

Fler avsnitt av The Long Run with Luke Timmerman

Visa alla avsnitt av The Long Run with Luke Timmerman
Ep203: Sri Kosuri on Small Molecule Correctors of Disease
•1 tim 12 min
Ep202: Becky Pferdehirt on Reimagining Science for the AI Era
•1 tim 8 min
Ep200: Richard Pops Reflects on a 35-Year Career in Biotech
•1 tim 14 min
Ep199: Martin Burke on Making Small Molecule Medicines for the AI Era
•1 tim 10 min
Ep198: Abbas Kazimi on Computation and Culture for Drug Discovery
•1 tim 17 min
Ep197: Viswa Colluru on Discovering Drugs Inspired by Mother Nature
•1 tim 17 min
Ep196: Otello Stampacchia on Europe's Biotech Crisis
•1 tim 3 min
Ep195: Ken Song on T-cell Engagers for Autoimmune Diseases
•1 tim 6 min
Ep194: Ansu Satpathy on Cancer and Autoimmune Drug Discovery
•1 tim 9 min
Ep193: Ron Renaud on Helping People Lose Weight With GLP-1 Medicines
•1 tim 5 min

The Long Run with Luke Timmerman med Timmerman Report finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.